Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120893) titled 'Mechanistic Investigation of Keloidogenesis Modulated by Mitochondrial Signaling via Mast-Cell-Derived Mediators' on March 22.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: The First Affiliated Hospital of Xiamen University

Condition: Keloid

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-22

Target Sample Size: Keloid observation group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=309393

Published by HT Digital Content Services with permission from Health Daily Digest....